Talk on:

Polymeric Nano carriers For Cancer Therapy

Dr. Hasan's scientific efforts are focused on photochemistry-based
approaches (photodynamic therapy, or PDT) for treatment and
diagnosis of disease. The overall strategy is to develop molecular
mechanisms and optical imaging-based combination treatment
regimens where one treatment arm involves light activation of certain
near-infrared-absorbing chemicals. This program identifies various
cellular and molecular targets for specific diseases and designs
constructs for optimal photochemical treatment effects. The targeting
.
entities include photoactivatable nanoparticles and small molecules.
In cancer, the focus malignancies are ovarian, prostate, pancreas and
head and neck cancers. In infections and infectious diseases, efforts Dr Tayyaba Hasan
are targeted toward developing microbial-enzyme-specific Professor of Dermatology
photoactivatable molecules for use in PDT. Dr. Tayyaba has 54 patents Wellman Center for Photomedicine,
on her credits (13 exclusively U.S. and 1 Commercialized). Her work on Harvard Medical School
macular degeneration is widely practiced in clinic. Massachusetts General Hospital
Boston, USA

Contact at:
Date & Time: March 9, 2023 (Thursday) at 11.00 am +92(051)2207380 Extn: 3021
Venu: Lyceum, A- Block, PIEAS ahmat@pieas.edu.pk
Photonano Medicine Research Laboratory
DPAM, PIEAS